These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The relationship between the dose of dentogingival plaque and the in vitro lymphoproliferative response in subjects with periodontal disease. Church H; Dolby AE J Oral Pathol; 1978 Oct; 7(5):318-25. PubMed ID: 102743 [TBL] [Abstract][Full Text] [Related]
46. The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Dennison DK; Van Dyke TE Periodontol 2000; 1997 Jun; 14():54-78. PubMed ID: 9567966 [No Abstract] [Full Text] [Related]
47. Letter to the editor: re: Saliva and serum levels of pentraxin-3 and interleukin-1β in generalized aggressive or chronic periodontitis. Gümüş P, Nizam N, Nalbantsoy A, Özçaka Ö, Buduneli N. (J Periodontol 2014;85:e40-e46.). Agilli M; Aydin FN; Cayci T; Kurt YG J Periodontol; 2015 Apr; 86(4):486. PubMed ID: 25828956 [No Abstract] [Full Text] [Related]
48. [Structural characteristics of mixed saliva in patients with early forms of periodontal inflammations]. Leont'ev VK; Galiulina MV; Ganzina IV; Anisimova IV; Kurochkin KA; Chesnokov VA Stomatologiia (Mosk); 2003; 82(4):32-3. PubMed ID: 12931418 [No Abstract] [Full Text] [Related]
49. [Periodontal status of Moscow schoolchildren]. Grudianov AI; Kiriukhina SA; Vorob'ev VS Stomatologiia (Mosk); 1985; 64(6):16. PubMed ID: 3866387 [No Abstract] [Full Text] [Related]
50. Periodontitis and concentrations of the cellular immune activation marker neopterin in saliva and urine. Vrecko K; Staedtler P; Mischak I; Maresch L; Reibnegger G Clin Chim Acta; 1997 Dec; 268(1-2):31-40. PubMed ID: 9495569 [TBL] [Abstract][Full Text] [Related]
51. Proteases and inhibitors in the plasma of patients with periodontal disease. Zafiropoulos GG; Eldanassouri N; Flores-de-Jacoby L; Kolb G; Havemann K; Prinz H J Periodontal Res; 1988 Jul; 23(4):281-2. PubMed ID: 2972825 [No Abstract] [Full Text] [Related]
52. Letter to the editor: Authors' response. Gümüş P; Nizam N; Özçaka Ö; Buduneli N; Nalbantsoy A J Periodontol; 2015 Apr; 86(4):486-8. PubMed ID: 25828957 [No Abstract] [Full Text] [Related]
53. Gingivitis and periodontitis in children and adolescents suffering from type 1 diabetes mellitus. Daković D; Mileusnić I; Hajduković Z; Čakić S; Hadži-Mihajlović M Vojnosanit Pregl; 2015 Mar; 72(3):265-73. PubMed ID: 25958479 [No Abstract] [Full Text] [Related]
54. [In vitro studies of hemocompatibility of surface modified fluoropolymers]. Zinner G; Werner C; Behrend D; König U; Caro JC; Sperling C; Schmitz KP; Jacobasch HJ Biomed Tech (Berl); 1998; 43 Suppl():394-5. PubMed ID: 9859414 [No Abstract] [Full Text] [Related]
55. Molecular characterization of complement components (C3, C4, and factor B) in human saliva. Andoh A; Fujiyama Y; Kimura T; Uchihara H; Sakumoto H; Okabe H; Bamba T J Clin Immunol; 1997 Sep; 17(5):404-7. PubMed ID: 9327340 [TBL] [Abstract][Full Text] [Related]
56. Serum and salivary C3a concentrations in human periodontitis. Hosni MM; Zenaib AS; Omaima LG Egypt Dent J; 1989 Jul; 35(3):231-44. PubMed ID: 2487299 [No Abstract] [Full Text] [Related]
57. [Humoral immunity at the serum and saliva levels in periodontopathies]. Vergano V; Praglia E; Carnovale G; Barone Monfrin S Minerva Stomatol; 1985; 34(2):339-42. PubMed ID: 3858648 [No Abstract] [Full Text] [Related]
58. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. Górska R; Gregorek H; Kowalski J; Laskus-Perendyk A; Syczewska M; Madaliński K J Clin Periodontol; 2003 Dec; 30(12):1046-52. PubMed ID: 15002890 [TBL] [Abstract][Full Text] [Related]
59. [Serum immunoglobulins and complement components in patients with periodontal disease]. Huang JS; Chen CC; Ho KY; Wu YM; Hou GL; Wang JC; Tsai CC Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Apr; 1(4):210-8. PubMed ID: 3869829 [No Abstract] [Full Text] [Related]